Recent Commentaries tagged (gild)
Generic Challenge for UTHR's Remodulin -...
United Therapeutics Corporation (UTHR) is facing a patent challenge for its lead product, Remodulin (treprostinil) injection. Sandoz, Novartis' (NVS) generic unit, is seeking approval for its generic version of Remodulin (10 mg/mL). The Paragraph IV Certification Notice Letter was received from...
Read More »
Tags: analyst-blog | gild | nvs | pfe | uthr
Company News for February 6, 2012 -...
o Estee Lauder Companies, Inc.'s (NYSE:EL) second quarter 2012 quarterly earnings increased 17% year over year to $1.00 per share, but missed the Zacks Consensus Estimate of $1.01 by a penny o After concerns arose that Idenix Pharmaceuticals, Inc.'s (Nasdaq:IDIX) hepatitis C drug would be unable...
Read More »
Tags: corporate-summary | el | gild | gnw | idix | sne | stocks
Jobs Report Drives Heavy Trading Traffic In...
Today's tickers: F, GM, MAS & GILD Options commentary to resume on Tuesday February 7th. F - Ford Motor Co. - The better-than-expected jobs number out this morning revved up investor appetite for automobile stocks, driving shares in Ford Motor Co. up 4.0% to $12.75. Call options on the U.S. auto...
Read More »
Tags: stocks | f | gild | gm | mas
Gilead Misses EPS Ests, Sales Up - Analyst Blog
Gilead Sciences Inc.'s (GILD) adjusted earnings per share (EPS) of 92 cents (including stock option expense) for the fourth quarter of 2011 missed the Zacks Consensus Estimate by 8 cents, as higher revenues were offset by increased research and development (R&D) expenses. However, the earnings we...
Read More »
Tags: analyst-blog | bmy | gild | jnj | stocks
Gilead Clinches Pharmasset Buy - Analyst Blog
Gilead Sciences, Inc. (GILD) announced recently that it has completed its previously announced agreement to buy Pharmasset, Inc, a maker of drugs for the treatment of chronic hepatitis C virus (HCV), for approximately $11.2 billion. Gilead paid $137 for each share of Pharmasset. Gilead had entere...
Read More »
Tags: analyst-blog | bmy | gild | inhx | mrk | rhhby | vrtx | stocks
